Aurora Kinase Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
- Submitted by: shekharm
- Views: 136
- Category: Science
- Date Submitted: 08/24/2015 11:51 PM
- Pages: 4
- Report this Essay
Single User License:
Aurora Kinase Inhibitors Market Global Industry Analysis, Size,
Share, Growth, Trends And Forecast
2015 - 2023
USD 4315.5
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
Flat 10% Discount!!
Free Customization as per your requirement
You will get Custom Report at Syndicated Report
price
Report will be delivered with in 15-20 working days
Request Sample
Buy Now
REPORT DESCRIPTION
The Aurora kinases are enzymes which are crucial for cell proliferation. These enzymes are responsible for dividing
genetic material of the parent cell during the process of mitosis by controlling chromatid segregation. The defect
related to this process is largely associated with cancer genesis in human body. In this way active involvement of
aurora kinase enzymes in initiating cancer genesis has lead considerable attention of therapists to their inhibition in
the work towards cancer treatment. There are three kind of aurora kinase found in human body namely A, B and C.
Aurora C is mainly restricted to the process of spermatogenesis while remaining two are responsible various
tumerogenesis.
Browse Full
market.html
Report
with
TOC
@
http://www.transparencymarketresearch.com/aurora-kinase-inhibitors-
Cancer is considered to the major causative factor for mortality worldwide with increasing incidence and prevalence
day by day. All regions of the world have seen continuous rise in number of cancer patients in past decade. WHO
predicted that annual cancer cases will reach to 19.3 million by 2025 from the 14.1 million annually in year 2012,
whereas annual cases in 2008 were 12.7 million of which 1.7 million were women newly diagnosed with breast
cancer that accounted for 20% in 2008. WHO mentions that cancer kills 8.2 millions globally out of which 522,000
woman from breast cancer. It is mentionable that incidence rate is still...
Aurora Kinase Inhibitors Market Global Industry Analysis, Size,
Share, Growth, Trends And Forecast
2015 - 2023
USD 4315.5
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
Flat 10% Discount!!
Free Customization as per your requirement
You will get Custom Report at Syndicated Report
price
Report will be delivered with in 15-20 working days
Request Sample
Buy Now
REPORT DESCRIPTION
The Aurora kinases are enzymes which are crucial for cell proliferation. These enzymes are responsible for dividing
genetic material of the parent cell during the process of mitosis by controlling chromatid segregation. The defect
related to this process is largely associated with cancer genesis in human body. In this way active involvement of
aurora kinase enzymes in initiating cancer genesis has lead considerable attention of therapists to their inhibition in
the work towards cancer treatment. There are three kind of aurora kinase found in human body namely A, B and C.
Aurora C is mainly restricted to the process of spermatogenesis while remaining two are responsible various
tumerogenesis.
Browse Full
market.html
Report
with
TOC
@
http://www.transparencymarketresearch.com/aurora-kinase-inhibitors-
Cancer is considered to the major causative factor for mortality worldwide with increasing incidence and prevalence
day by day. All regions of the world have seen continuous rise in number of cancer patients in past decade. WHO
predicted that annual cancer cases will reach to 19.3 million by 2025 from the 14.1 million annually in year 2012,
whereas annual cases in 2008 were 12.7 million of which 1.7 million were women newly diagnosed with breast
cancer that accounted for 20% in 2008. WHO mentions that cancer kills 8.2 millions globally out of which 522,000
woman from breast cancer. It is mentionable that incidence rate is still...